SUCCESSFUL GENERATION OF TUMOR-INFILTRATING LYMPHOCYTE (TIL) PRODUCT FROM RENAL CELL CARCINOMA (RCC) TUMORS FOR ADOPTIVE CELL THERAPY

被引：1
|
作者：
Halbert, Brian
Einstein, David
McDermott, David
Andrianopoulos, Emanuelle
Gupta, Mamta
Seery, Virginia
Onimus, Kenneth
Herman, Courtney
Wells, Adrian
Lakshmipathi, Shwetha
Natarajan, Arvind
Veerapathran, Anand
Bhatt, Rupal
Halbert, Brian
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.176
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
176
引用
收藏
页码：A188 / A188
页数：1
相关论文
共 50 条
  • [1] Successful Generation of Tumor-Infiltrating Lymphocytes (TIL) for Adoptive Cell Therapy from Mesothelioma
    Fennell, D. A.
    Poile, C.
    Bzura, A.
    Dzialo, J.
    Nakas, A.
    Kutywayo, K.
    Natarajan, A.
    Herman, C.
    Kovatch, R.
    Bunch, B.
    Veerapathran, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S381 - S382
  • [2] Pilot Trial of Ipilimumab and Adoptive Tumor-infiltrating Lymphocyte (TIL) Cell Therapy
    Prabhakaran, S.
    Woods, D. M.
    Royster, E. B.
    Zager, J. S.
    Sondak, V. K.
    Pilon-Thomas, S.
    Sarnaik, A. A.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S23 - S23
  • [3] Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy
    Einstein, David J.
    Halbert, Brian
    Denize, Thomas
    Matar, Sayed
    West, Destiny J.
    Gupta, Mamta
    Andrianopoulos, Emanuelle
    Seery, Virginia
    Herman, Courtney
    Onimus, Kenneth
    Wells, Adrian
    Bunch, Brittany
    Signoretti, Sabina
    Natarajan, Arvind
    Veerapathran, Anand
    McDermott, David F.
    JOURNAL OF IMMUNOTHERAPY, 2024, 47 (09) : 361 - 368
  • [4] Generation and Characterization of Ex Vivo Expanded Tumor-Infiltrating Lymphocytes from Renal Cell Carcinoma Tumors for Adoptive Cell Therapy
    Einstein, David
    ONCOLOGIST, 2024, 29 : S26 - S27
  • [5] Ex vivo expansion of tumor infiltrating lymphocytes (TIL) from human renal cell carcinoma (RCC) tumors
    Alkhouli, Mohammed
    Martinez-Brockhus, Veronica
    Beatty, Matthew S.
    Gillies, Robert J.
    Pilon-Thomas, Shari
    Chahoud, Jad
    CANCER RESEARCH, 2022, 82 (12)
  • [6] Preclinical development of adoptive cell therapy with tumor-infiltrating lymphocytes for patients with renal cell carcinoma
    Andersen, R.
    Westergaard, M. C. W.
    Kjeldsen, J. W.
    Donia, M.
    Svane, I. M.
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [7] ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors
    Hulen, Thomas Morgan
    Chamberlain, Christopher Aled
    Svane, Inge Marie
    Met, Ozcan
    IMMUNO, 2021, 1 (03): : 194 - 211
  • [8] Effect of sunitinib pretreatment on yield from tumor-infiltrating lymphocyte (TIL) cultures in patients with renal cell carcinoma.
    Bex, Axel
    Guislain, Aurelie
    van Boven, Hester
    Blank, Christian U.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [9] Tumor-infiltrating lymphocyte diversity and clear cell renal cell carcinoma.
    Ferrall-Fairbanks, Meghan C.
    Chakiryan, Nicholas
    Chobrutskiy, Boris I.
    Kim, Youngchul
    Teer, Jamie K.
    Berglund, Anders
    Mule, James
    Fournier, Michelle
    Siegel, Erin M.
    Katende, Esther N.
    Blanck, George
    Manley, Brandon J.
    Altrock, Philipp M.
    CANCER RESEARCH, 2021, 81 (13)
  • [10] Preclinical development of tumor-infiltrating lymphocyte (TIL) based adoptive cell transfer (ACT) immunotherapy for patients with sarcoma
    Nielsen, M.
    Krarup-Hansen, A.
    Hovgaard, D.
    Petersen, M. M.
    Loya, A. C.
    Junker, N.
    Svane, I. M.
    ANNALS OF ONCOLOGY, 2016, 27
12345